PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima, 770-8514, Japan. Electronic address: daihatake926@ph.bunri-u.ac.jp.\', \'Department of Pharmaceutical Microbiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, 862-0973, Japan.\', \'Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima, 770-8514, Japan.\', \'Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Tokushima, 770-8514, Japan. Electronic address: kuzuhara@ph.bunri-u.ac.jp.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0006-291X(21)00593-310.1016/j.bbrc.2021.03.173
?:doi
?:hasPublicationType
?:journal
  • Biochemical and biophysical research communications
is ?:pmid of
?:pmid
?:pmid
  • 33894414
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.087
?:rankingScore_hIndex
  • 237
is ?:relation_isRelatedTo_publication of
?:title
  • In-vitro acetylation of SARS-CoV and SARS-CoV-2 nucleocapsid proteins by human PCAF and GCN5.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all